LOW DOSE POSTTRANSPLANTATION CYCLOPHOSPHAMIDE CAN ENHANCE THE PROTECTIVE EFFECT OF ATG /G-CSF ON GVHD: RESULTS OF A PHASE II PROSPECTIVE TRIAL

被引：0
|
作者：
Wang, Y. [1 ]
Chang, Y. -J. [1 ]
Huang, X. -J. [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1517
引用
收藏
页码：618 / 619
页数：2
相关论文
共 50 条
  • [41] The Efficacy and Safety of Decitabine in Combination with ATRA, G-CSF and Low Dose Cytarabine(Dlaag Regimen)in Relapsed/Refractory Acute Myeloid Leukemia Not Suitable for Strong Chemotherapy : A Phase 2, Prospective, Single-Arm, Multicenter Study
    Yang, Li
    Liu, Ligen
    Zhao, Limin
    Lu, Yingting
    Zhang, Jing
    Sun, Lihua
    BLOOD, 2019, 134
  • [42] In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML:: results from a prospective phase II study
    Bonifazi, F
    Bandini, G
    Stanzani, M
    Palandri, F
    Giannini, B
    Arpinati, M
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 (10) : 1025 - 1026
  • [43] In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study
    F Bonifazi
    G Bandini
    M Stanzani
    F Palandri
    B Giannini
    M Arpinati
    G Rosti
    M Baccarani
    Bone Marrow Transplantation, 2005, 35 : 1025 - 1026
  • [44] A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531
    Masters, Gregory A.
    Wang, Xiaofei
    Hodgson, Lydia
    Shea, Thomas
    Vokes, Everett
    Green, Mark
    LUNG CANCER, 2011, 74 (02) : 258 - 263
  • [45] MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD.
    Vaughan, WP
    Katz, RO
    Salzman, DE
    Tilden, AB
    Lopez, RD
    Garcia, A
    Pena, O
    Shackelford, M
    Carabasi, MH
    BLOOD, 2001, 98 (11) : 200A - 200A
  • [46] Low-dose Fractionated Radiation (LDFRT) as a Chemopotentiator of Neoadjuvant Paclitaxel and Carboplatin for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: 5 Year Results Of A Prospective Phase II Trial
    Gleason, J. F.
    Kudrimoti, M.
    Van Meter, E. M.
    Mohiuddin, M.
    Regine, W. F.
    Valentino, J.
    Arnold, S. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S502 - S503
  • [47] The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage:: results of a single center prospective Phase II trial
    Haenggi, Daniel
    Liersch, Julia
    Turowski, Bernd
    Yong, Mei
    Steiger, Hans-Jakob
    JOURNAL OF NEUROSURGERY, 2008, 108 (06) : 1192 - 1199
  • [48] A phase II trial of filgrastim (G-CSF) supported high dose sequential chemotherapy and peripheral blood stem cell (PBSC) transplantation as initial therapy for high risk non-Hodgkin's lymphoma(NHL): A multicenter pilot study.
    Schenkein, DP
    Roitman, D
    Miller, KB
    Morelli, J
    Stadtmauer, E
    Pecora, AL
    Cassileth, P
    Lazarus, HM
    BLOOD, 1996, 88 (10) : 462 - 462
  • [49] A phase II trial of filgrastim (G-CSF) supported high dose sequential chemotherapy and peripheral bood stem cell (PBSC) transplantation as initial therapy for high risk non-hodskin's Lymphoma(NHL): A multicenter pilot study.
    Schenkein, DP
    Miller, KB
    Sweet, M
    Rosenbach, M
    Stadtmauer, E
    Cassileth, P
    Cooper, B
    Lazarus, HM
    BLOOD, 1995, 86 (10) : 3844 - 3844
  • [50] Combined Analysis of a Phase III Randomized Trial and Phase II Prospective Trial with Blind Control Matching of Patients Receiving Whole-Lung, Low-Dose Radiation for COVID-19: Full Results and Immunologic Correlates of the RESCUE 1-19 Trial
    Hess, C. B.
    Eng, T. Y.
    Nasti, T.
    Dhere, V. R.
    Kleber, T.
    Switchenko, J.
    Weinberg, B. D.
    Rouphael, N.
    Tian, S.
    Rudra, S.
    Olabode, K.
    Samuel, E.
    Ahmed, R.
    Khan, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E179 - E179
12345